Galcanezumab-induced psoriasis-like lesions of the eyebrows: A case report and review of CGRP's role in cutaneous inflammation
Introduction Anti-calcitonin gene-related peptide (CGRP) monoclonal antibodies have shown excellent efficacy and tolerability in patients with migraine. However, their systemic side effects, particularly on the skin, where CGRP plays a key role in regulating inflammation and immune responses, are no...
Saved in:
| Main Authors: | Patricia Díaz-Corta, Sergio Campoy, Lidia Termens, Andrea Bauer, Jaume Campdelacreu, Joan Prat, Mariano Huerta-Villanueva, Albert Muñoz-Vendrell |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-08-01
|
| Series: | Cephalalgia Reports |
| Online Access: | https://doi.org/10.1177/25158163251371684 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
20474. EL SWITCH DE ANTI-CGRP EN MIGRAÑA PUEDE BENEFICIAR A UN 25% DE LOS PACIENTES QUE NO RESPONDEN AL PRIMER FÁRMACO: ESTUDIO RETROSPECTIVO DE 82 CASOS
by: A. Muñoz Vendrell, et al.
Published: (2024-11-01) -
Croatian guidelines for specific preventive treatment of migraine with monoclonal antibodies targeting calcitonin gene-related peptide (CGRP) (eptinezumab, fremanezumab, and galcanezumab) or the CGRP receptor (erenumab)
by: Davor Jančuljak, et al.
Published: (2024-01-01) -
20589. PRESCRIPCIÓN INICIAL DE LASMIDITÁN EN VIDA REAL: PERFIL DE PACIENTE, ADHERENCIA Y PRIMERAS EXPERIENCIAS
by: P. Díaz Corta, et al.
Published: (2024-11-01) -
Supraorbital eyebrow approach to skull base lesions
by: Yvens Barbosa Fernandes, et al.
Published: (2002-06-01) -
[Translated article] Cutaneous Sarcoidosis after Platelet-Rich Plasma Injections and Permanent Eyebrow Make-Up
by: D. Martín-Torregrosa, et al.
Published: (2024-11-01)